Evan Lyall net worth
Quick answer
Evan Lyall's estimated net worth is $10.0M (range $7.0M – $15.0M) as of 2026. Evan Lyall is Founder at Rosebud Biosciences. Rosebud Biosciences valuation.
Evan Lyall is Founder at Rosebud Biosciences (YC W22). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Stanford University
- Region: United States of America
- Industries: Healthcare, Drug Discovery and Delivery
- Team size: 3
- Website: https://rosebudbiosciences.com/
Who is Evan Lyall?
Evan Lyall is a founder at Rosebud Biosciences, a company that focuses on cannabis-based therapeutics.
Highlights:
- Stanford University
- Hale Bio
- Venture backed
About Rosebud Biosciences
Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This...
FAQ: Evan Lyall net worth and Rosebud Biosciences valuation
What is Evan Lyall's net worth?
Evan Lyall's estimated net worth is $10.0M (range $7.0M – $15.0M) as of 2026. Evan Lyall is Founder at Rosebud Biosciences. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Rosebud Biosciences valuation?
Rosebud Biosciences's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Evan Lyall's role?
Evan Lyall is Founder at Rosebud Biosciences, a Y Combinator-backed startup (batch W22).